Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes

Reductions in hemoglobin and packed cell volume over 3 years in UKPDS patients with newly diagnoses Type 2 Diabetes

Diabetes increases the risk for developing anemia by 2-3 fold, compared to those without diabetes and similar renal function. We examined hemoglobin (Hb) and packed cell volume (PCV) changes over three years in UK Prospective Diabetes Study (UKPDS) patients with newly-diagnosed type 2 diabetes rando...

Podrobná bibliografie
Hlavní autor:	Coleman, R
Médium:	Conference item
Vydáno:	American Diabetes Association 2016

Podobné jednotky

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.
Autor: Davis, T, a další
Vydáno: (2013)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
Autor: Wamil, M, a další
Vydáno: (2021)

Cardiovascular Risk Assessment with Vascular Function, Carotid Atherosclerosis and the UKPDS Risk Engine in Korean Patients with Newly Diagnosed Type 2 Diabetes
Autor: Choon Sik Seon, a další
Vydáno: (2011-12-01)

Plasma lipids and hypoglycaemic therapies over 6 years in Type 2 diabetic patients in the UKPDS
Autor: Cull, C, a další
Vydáno: (1999)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Autor: Matthews, DR, a další
Vydáno: (1998)

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation
Autor: Coleman, R, a další
Vydáno: (2005)

Efficacy over six years of sulphonylurea plus insulin therapy in type 2 diabetic patients in the UKPDS
Autor: Cull, C, a další
Vydáno: (2000)

Hypoglycaemia in patients with Type 2 diabetes in the UKPDS
Autor: Cull, C, a další
Vydáno: (2001)

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).
Autor: Davis, T, a další
Vydáno: (2005)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).
Autor: Stevens, R, a další
Vydáno: (2001)

Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).
Autor: Kohner, E, a další
Vydáno: (2001)

Parathyroid Hormone is Negatively Correlated with Glycated Hemoglobin in Newly Diagnosed Type 2 Diabetic Patients
Autor: Xueqing He, a další
Vydáno: (2024-01-01)

The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes
Autor: Rui Min, a další
Vydáno: (2023-11-01)

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.
Autor: Stratton, I, a další
Vydáno: (2001)

Estimating risk of clinically evident neuropathy in Type 2 diabetes: a UKPDS risk equation
Autor: Coleman, R, a další
Vydáno: (2006)

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine
Autor: Coleman, R, a další
Vydáno: (2007)

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years
Autor: Matthews, DR, a další
Vydáno: (1998)

Forecasting coronary case fatality in type 2 diabetes: a UKPDS Risk Engine equation
Autor: Stevens, R, a další
Vydáno: (2002)

Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
Autor: Cull, C, a další
Vydáno: (2004)

Ethnic differences in diabetic nephropathy - The UKPDS
Autor: Stevens, R, a další
Vydáno: (1999)

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Autor: Alva, M, a další
Vydáno: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83).
Autor: Davis, T, a další
Vydáno: (2014)

Ethnicity and long-term vascular outcomes in Type 2 diabetes: A prospective observational study (UKPDS 83)
Autor: Davis, T, a další
Vydáno: (2014)

Framingham equations underestimate cardiovascular risk compared with the UKPDS risk engine in people with Type 2 diabetes
Autor: Price, H, a další
Vydáno: (2007)

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).
Autor: Wright, A, a další
Vydáno: (2002)

RETINOPATHY IN THE UKPDS TRIAL MICRO-ANEURYSM COUNTS AND THE RISKS OF PROGRESSION OVER 3-YEARS AND 6-YEARS
Autor: Matthews, D, a další
Vydáno: (1995)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
Autor: Coleman, RL, a další
Vydáno: (2019)

A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68).
Autor: Clarke, P, a další
Vydáno: (2004)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Autor: Joonyub Lee, a další
Vydáno: (2021-05-01)

Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Autor: Joonyub Lee, a další
Vydáno: (2021-07-01)

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
Autor: Stevens, R, a další
Vydáno: (2004)

Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Autor: Adler, AI, a další
Vydáno: (2024)

UKPDS: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects
Autor: Widjaja, A, a další
Vydáno: (1996)

Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS
Autor: Holman, R, a další
Vydáno: (2001)

Genetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes.
Autor: Gloyn, A, a další
Vydáno: (2008)

Inaugural Conference: UKPDS Legacy and Precision Therapy for Type 2 Diabetes Mellitus
Autor: Rury Holman
Vydáno: (2022-09-01)

Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
Autor: Lind, M, a další
Vydáno: (2021)

UKPDS - 6-YEAR TRIAL OF SULFONYLUREA, INSULIN AND METFORMIN THERAPY IN TYPE-2 DIABETIC-PATIENTS WITH DIET FAILURE
Autor: Cull, C, a další
Vydáno: (1995)

Ukpds risk engine
Autor: Daniel Pinto
Vydáno: (2011-01-01)

UKPDS: what was the question? UK Prospective Diabetes Study.
Autor: Turner, R, a další
Vydáno: (1999)